PrEP Biopharm

About:

PrEP Biopharm is a developer of respiratory infectious disease products.

Website: http://www.prepbiopharm.com/

Top Investors: Johnson & Johnson Robotics and Digital Solutions, hVIVO

Description:

PrEP Biopharm is a biopharmaceutical company. That focused on the prevention of respiratory infections. They prevent upper respiratory tract viral infections. PrEP-001 is a phase 2 nasal spray that increases the host's innate immune response and protects against all respiratory viruses and is predicted to be used to combat respiratory viral pandemics such as COVID-19.